David Stokoe
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
David Stokoe has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
- Ari J. Firestone
Calico Life Sciences LLC, South San Francisco, California
58 shared publications - Jeffrey Settleman
Calico Life Sciences LLC, South San Francisco, California
46 shared publications - Ganesh Kolumam
Calico Life Sciences LLC, South San Francisco, California
45 shared publications - Lisa Choy
Calico Life Sciences LLC, South San Francisco, California
45 shared publications - Stephen Norris
Calico Life Sciences LLC, South San Francisco, California
45 shared publications - Xiumin Wu
Calico Life Sciences LLC, South San Francisco, California
45 shared publications
Latest Publications
- Open Access
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Table S4 from Loss of UXS1 Selectively Depletes Pyrimidines and Induces Replication Stress in KEAP1-Mutant Lung Cancer
Guide information for LNP studies
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S4 from Loss of UXS1 Selectively Depletes Pyrimidines and Induces Replication Stress in KEAP1-Mutant Lung Cancer
Guide information for LNP studies
- Open Access
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Figure S4 from Loss of UXS1 Selectively Depletes Pyrimidines and Induces Replication Stress in KEAP1-Mutant Lung Cancer
DNA replication stress resulting from UXS1 loss leads to states of cell-cycle exit and apoptosis
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from Loss of UXS1 Selectively Depletes Pyrimidines and Induces Replication Stress in KEAP1-Mutant Lung Cancer
DNA replication stress resulting from UXS1 loss leads to states of cell-cycle exit and apoptosis
- Open Access
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Table S2 from Loss of UXS1 Selectively Depletes Pyrimidines and Induces Replication Stress in KEAP1-Mutant Lung Cancer
Significantly enriched or depleted guides from CRISPR knockout screen
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S2 from Loss of UXS1 Selectively Depletes Pyrimidines and Induces Replication Stress in KEAP1-Mutant Lung Cancer
Significantly enriched or depleted guides from CRISPR knockout screen
- Open Access
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Figure S6 from Loss of UXS1 Selectively Depletes Pyrimidines and Induces Replication Stress in KEAP1-Mutant Lung Cancer
UXS1 loss sensitizes KEAP1-mutant cells to cell-cycle checkpoint kinase inhibitors
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S6 from Loss of UXS1 Selectively Depletes Pyrimidines and Induces Replication Stress in KEAP1-Mutant Lung Cancer
UXS1 loss sensitizes KEAP1-mutant cells to cell-cycle checkpoint kinase inhibitors
- Open Access
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Figure S7 from Loss of UXS1 Selectively Depletes Pyrimidines and Induces Replication Stress in KEAP1-Mutant Lung Cancer
UXS1 loss is well tolerated by normal mouse livers, a tissue with high UGDH expression
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S7 from Loss of UXS1 Selectively Depletes Pyrimidines and Induces Replication Stress in KEAP1-Mutant Lung Cancer
UXS1 loss is well tolerated by normal mouse livers, a tissue with high UGDH expression
- Open Access
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Figure S5 from Loss of UXS1 Selectively Depletes Pyrimidines and Induces Replication Stress in KEAP1-Mutant Lung Cancer
CRISPR knockout screening reveals additional effectors of sensitivity to UXS1 loss
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from Loss of UXS1 Selectively Depletes Pyrimidines and Induces Replication Stress in KEAP1-Mutant Lung Cancer
CRISPR knockout screening reveals additional effectors of sensitivity to UXS1 loss
- Open Access
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Table S3 from Loss of UXS1 Selectively Depletes Pyrimidines and Induces Replication Stress in KEAP1-Mutant Lung Cancer
Table S3 from Loss of UXS1 Selectively Depletes Pyrimidines and Induces Replication Stress in KEAP1-Mutant Lung Cancer
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S3 from Loss of UXS1 Selectively Depletes Pyrimidines and Induces Replication Stress in KEAP1-Mutant Lung Cancer
Table S3 from Loss of UXS1 Selectively Depletes Pyrimidines and Induces Replication Stress in KEAP1-Mutant Lung Cancer
- Open Access
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Figure S3 from Loss of UXS1 Selectively Depletes Pyrimidines and Induces Replication Stress in KEAP1-Mutant Lung Cancer
UXS1 loss in KEAP1-mutant cancer cells causes DNA replication stress
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from Loss of UXS1 Selectively Depletes Pyrimidines and Induces Replication Stress in KEAP1-Mutant Lung Cancer
UXS1 loss in KEAP1-mutant cancer cells causes DNA replication stress
- Open Access
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Figure S1 from Loss of UXS1 Selectively Depletes Pyrimidines and Induces Replication Stress in KEAP1-Mutant Lung Cancer
KEAP1-mutant NSCLC cells are sensitive to UXS1 loss in a UGDH expression-dependent manner
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from Loss of UXS1 Selectively Depletes Pyrimidines and Induces Replication Stress in KEAP1-Mutant Lung Cancer
KEAP1-mutant NSCLC cells are sensitive to UXS1 loss in a UGDH expression-dependent manner
- Open Access
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Key Resources Table from Loss of UXS1 Selectively Depletes Pyrimidines and Induces Replication Stress in KEAP1-Mutant Lung Cancer
Critical reagents used with corresponding identifiers
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessKey Resources Table from Loss of UXS1 Selectively Depletes Pyrimidines and Induces Replication Stress in KEAP1-Mutant Lung Cancer
Critical reagents used with corresponding identifiers